Metro Brands Limited (NSE:METROBRAND)

Verve Therapeutics Revenue

Metro Brands had revenue of 6.28B INR in the quarter ending June 30, 2025, with 9.05% growth. This brings the company's revenue in the last twelve months to 25.60B, up 8.90% year-over-year. In the fiscal year ending March 31, 2025, Metro Brands had annual revenue of 25.07B with 6.39% growth.

• Revenue (ttm): 25.60B
• Revenue Growth: +8.90%
• P/S Ratio: 11.78
• Revenue / Employee: 6.55M
• Employees: 3,908
• Market Cap: 301.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	25.07B	1.51B	6.39%
Mar 31, 2024	23.57B	2.30B	10.79%
Mar 31, 2023	21.27B	7.84B	58.39%
Mar 31, 2022	13.43B	5.43B	67.85%
Mar 31, 2021	8.00B	-4.85B	-37.75%